Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas
J Kesavadev, B Saboo, MB Krishna, G Krishnan - Diabetes Therapy, 2020 - Springer
The year 2021 will mark 100 years since the discovery of insulin. Insulin, the first medication
to be discovered for diabetes, is still the safest and most potent glucose-lowering therapy …
to be discovered for diabetes, is still the safest and most potent glucose-lowering therapy …
[HTML][HTML] Machine learning application in autoimmune diseases: State of art and future prospectives
MG Danieli, S Brunetto, L Gammeri, D Palmeri… - Autoimmunity …, 2024 - Elsevier
Autoimmune diseases are a group of disorders resulting from an alteration of immune
tolerance, characterized by the formation of autoantibodies and the consequent …
tolerance, characterized by the formation of autoantibodies and the consequent …
Machine learning techniques for hypoglycemia prediction: trends and challenges
(1) Background: the use of machine learning techniques for the purpose of anticipating
hypoglycemia has increased considerably in the past few years. Hypoglycemia is the drop in …
hypoglycemia has increased considerably in the past few years. Hypoglycemia is the drop in …
Artificial intelligence in decision support systems for type 1 diabetes
Type 1 diabetes (T1D) is a chronic health condition resulting from pancreatic beta cell
dysfunction and insulin depletion. While automated insulin delivery systems are now …
dysfunction and insulin depletion. While automated insulin delivery systems are now …
Data-based modeling for hypoglycemia prediction: Importance, trends, and implications for clinical practice
L Zhang, L Yang, Z Zhou - Frontiers in Public Health, 2023 - frontiersin.org
Background and objective Hypoglycemia is a key barrier to achieving optimal glycemic
control in people with diabetes, which has been proven to cause a set of deleterious …
control in people with diabetes, which has been proven to cause a set of deleterious …
Generation of individualized synthetic data for augmentation of the type 1 diabetes data sets using deep learning models
In this paper, we present a methodology based on generative adversarial network
architecture to generate synthetic data sets with the intention of augmenting continuous …
architecture to generate synthetic data sets with the intention of augmenting continuous …
A machine learning approach to minimize nocturnal hypoglycemic events in type 1 diabetic patients under multiple doses of insulin
Nocturnal hypoglycemia (NH) is one of the most challenging events for multiple dose insulin
therapy (MDI) in people with type 1 diabetes (T1D). The goal of this study is to design a …
therapy (MDI) in people with type 1 diabetes (T1D). The goal of this study is to design a …
Accuracy of Two Continuous Glucose Monitoring Devices During Aerobic and High-Intensity Interval Training in Individuals with Type 1 Diabetes
A Cuerda del Pino, R Martín-San Agustín… - Diabetes Technology …, 2024 - liebertpub.com
Background: This study aimed to evaluate the accuracy of Dexcom G6 (DG6) and FreeStyle
Libre-2 (FSL2) during aerobic training and high-intensity interval training (HIIT) in individuals …
Libre-2 (FSL2) during aerobic training and high-intensity interval training (HIIT) in individuals …
Role of artificial intelligence in pharmacy practice: a narrative review
A Wong, E Wentz, N Palisano, M Dirani… - Journal of the …, 2023 - Wiley Online Library
Artificial intelligence (AI) has emerged as a potentially useful tool in transforming healthcare.
Roles for AI include drug safety, operations, as well as precision medicine to improve patient …
Roles for AI include drug safety, operations, as well as precision medicine to improve patient …
Therapeutic role of kaempferol and myricetin in streptozotocin-induced diabetes synergistically via modulation in pancreatic amylase, glycogen storage and insulin …
Kaempferol and Myricetin alone have promising benefits on diabetes and related
complications, yet the effectiveness of cotreating the two compounds on diabetes have not …
complications, yet the effectiveness of cotreating the two compounds on diabetes have not …